Venocclusive disease of the liver after bone marrow transplantation: The role of hemostasis

References

• Sperl W., Stuppner H., Gassner I., Judmaier W., Dietze O., Vogel W. Reversible hepatic veno-occlusive disease in an infant after consumption of pyrrolizidine-containing herbal tea. European Journal of Pediatrics 1995; 154: 112–116
   PubMed Web of Science ®Google Scholar
• Chauvin P., Dillon J. C., Moren A. An outbreak of Heliotrope food poisoning, Tadjikistan, November 1992–March 1993. Sante 1994; 4: 263–268
   PubMedGoogle Scholar
• Kanwar V. S., Albuquerque M. L., Ribeiro R. C., Kauffman W. M., Furman W. L. Veno-occlusive disease of the liver after chemotherapy for rhabdomyosarcoma: case report with a review of the literature. Medical and Pediatric Oncology 1995; 24: 334–340
   PubMedGoogle Scholar
• Modzelewski J. R., Jr., Daeschner C., Joshi V. V., Mullick F. G., Ishak K. G. Veno-occlusive disease of the liver induced by low-dose cyclophosphamide. Modern Pathology 1994; 7: 967–972
   PubMed Web of Science ®Google Scholar
• Barclay K. L., Yeong M. L. Actinomycin D associated hepatic veno-occlusive disease: a report of 2 cases. Pathology 1994; 26: 257–260
   PubMed Web of Science ®Google Scholar
• Kao N. L., Rosenblate H. J. 6-Thioguanine therapy for psoriasis causing toxic hepatic veno-occlusive disease. Journal of the American Academy of Dermatology 1993; 28: 1017–1018
   PubMed Web of Science ®Google Scholar
• Mari T., Barlattani A., Cecchini T., Potenza B., Hassan C. Segmentary veno-occlusive disease of the liver secondary to insecticide inhalation. Clinica Terapeutica 1994; 144: 155–162
   PubMedGoogle Scholar
• Baglin T. P. Veno-occlusive disease of the liver complicating bone marrow transplantation. Bone Marrow Transplantation 1994; 13: 1–4
   PubMed Web of Science ®Google Scholar
• Shulman H., McDonald G., Mathews D. An analysis of hepatic venocclusive disease and centrilobular hepatic degeneration following bone marrow transplantation. Gastroenterology 1980; 79: 1178–1191
   PubMed Web of Science ®Google Scholar
• McDonald G., Sharma P., Mathews D., Shulman H., Thomas E. Venocclusive disease of the liver after bone marrow transplantation. Diagnosis, incidence and predisposing factors. Hepatology 1984; 4: 116–122
   PubMed Web of Science ®Google Scholar
• Shulman H. M., Fisher L. B., Schoch H. G., Henne K. W., McDonald G. B. Venocclusive disease of the liver after marrow transplantation: Histological correlates of clinical signs and symptoms. Hepatology 1994; 19: 1171–1180
   PubMed Web of Science ®Google Scholar
• Shulman H. M., Gown A. M., Nugent D. J. Hepatic veno-occlusive disease after bone marrow transplantation. Immunohistochemical identification of the material within occluded central venules. American Journal of Pathology 1987; 127: 549–558
   PubMed Web of Science ®Google Scholar
• Holler E., Kolb H., Möller A., Kempeni J., Liesenfeld S., Pechumer H., Lehmacher W., Ruckdeschel G., Gleixner B., Riedner C., Ledderose G., Brehm G., Mittermüller J., Wilmanns W. Increased serum levels of tumor necrosis factor a precede major complications of bone marrow transplantation. Blood 1990; 75: 1011–1016
   PubMed Web of Science ®Google Scholar
• Remberger M., Ringden O. Increased levels of soluble interleukin-2 receptor in veno-occlusive disease of the liver after allogenic bone marrow transplantation. Transplantation 1995; 60: 1293–1299
   PubMed Web of Science ®Google Scholar
• Jones R. J., Lee K. S. K., Beschorner W. E., Vogel V. G., Grochow L. B., Braine H. G., Vogelsang G. B., Sensenbrenner L. L., Santos G. W., Saral R. Venocclusive disease of the liver following bone marrow transplantation. Transplantation 1987; 44: 778–783
   PubMed Web of Science ®Google Scholar
• Bearman S. I., Anderson G. L., Mori M., Hinds M. S., Shulman H. M., McDonald G. B. Veno-occlusive disease of the liver: development of a model for predicting fatal outcome after marrow transplantation. Journal of Clinical Oncology 1993; 11: 1729–1736
   PubMed Web of Science ®Google Scholar
• McDonald G. B., Hinds M. S., Fisher L. D., Schoch, Wolford J. L., Banaji M., Hardin B. J., Shulman H. M., Clift R. A. Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients. Annals of Internal Medicine 1993; 118: 255–267
   PubMed Web of Science ®Google Scholar
• Ozkaynak M., Weinberg K., Kohn D., Sender L., Parkman R., Lenarsky C. Hepatic veno-occlusive disease post-bone marrow transplantation in children conditioned with busulfan and cyclophosphamide: incidence, risk factors and clinical outcome. Bone Marrow Transplantation 1991; 7: 467–474
   PubMed Web of Science ®Google Scholar
• Carreras E., Granena A., Rozman C. Hepatic veno-occlusive disease after bone marrow transplantation. Blood Reviews 1993; 7: 43–51
   PubMed Web of Science ®Google Scholar
• Frickhofen N., Wiesneth M., Jainta C., Hertenstein B., Heymer B., Bianchi L., Dienes H. P., Koerner K., Bunjes D., Arnold R., Kubanek B., Heimpel H. Hepatitis C virus infection is a risk factor for liver failure from venoocclusive disease after bone marrow transplantation. Blood 1994; 83: 1998–2004
   PubMed Web of Science ®Google Scholar
• Ljungman P., Hägglund H., Lönngvist B., Sönnerborg A., Ringden O. Hepatitis C virus as a risk factor for the development of veno-occlusive disease of the liver. Blood 1994; 84: 1349–1350
   PubMed Web of Science ®Google Scholar
• Gumucio J. J., Miller D. L. Functional implications of liver cell heterogeneity. Gastroenterology 1981; 80: 393–403
   PubMed Web of Science ®Google Scholar
• Andus T., Bauer J., Gerok W. Effects of cytokines on the liver. Hepatology 1991; 13: 364–375
   PubMed Web of Science ®Google Scholar
• Scoazec J-Y., Feldmann G. In situ immunophenotyping study of endothelial cells of the human hepatic sinusoid: results and functional implications. Hepatology 1991; 14: 789–797
   PubMed Web of Science ®Google Scholar
• Edgington T. S., Nackman N., Brand K., Ruf W. The structural biology of expression and function of tissue factor. Thrombosis and Haemostasis 1991; 66: 67–79
   PubMed Web of Science ®Google Scholar
• McDonald G. B., Sharma P., Mathews D., Shulman H., Thomas E. The clinical course of 53 patients with venocclusive disease of the liver after marrow transplantation. Transplantation 1985; 39: 603–608
   PubMed Web of Science ®Google Scholar
• Carreras E., Granena A., Navasa M., Bruguera M., Marco V., Sierra J., Tassies M. D., Garcia-Pagan J. C., Marti J. M., Bosch J. On the reliability of clinical criteria for the diagnosis of hepatic veno-occlusive disease. Annals of Hematology 1993; 66: 77–80
   PubMed Web of Science ®Google Scholar
• Shulman H. M., Gooley T., Dudley M. D., Kotler T., Feldman R., Dwyer D., Macdonald G. B. Utilty of transvenous liver biopsies and wedged hepatic venous pressure measurements in sixty marrow transplant recipients. Transplantation 1995; 59: 1015–1022
   PubMed Web of Science ®Google Scholar
• Nicolau C., Bru C., Carreras E., Bosch J., Bianchi L., Gilabert R., Vilana R. Sonographic diagnosis and hemodynamic correlation in veno-occlusive disease of the liver. Journal of Ultrasound Medicine 1993; 12: 437–440
   PubMed Web of Science ®Google Scholar
• Zieger M. M., Koscielniak E. Diagnosis and follow-up of veno-occlusive disease of the liver by use of Doppler ultrasound. A case report. Pediatric Radiology 1993; 23: 137–139
   PubMed Web of Science ®Google Scholar
• Deeg K. H., Glockel U., Richter R., Beck J. Diagnosis of veno-occlusive disease of the liver by color-coded Doppler sonography. Pediatric Radiology 1993; 23: 134–136
   PubMed Web of Science ®Google Scholar
• Teefey S. A., Brink J. A., Borson R. A., Middleton W. D. Diagnosis of venoocclusive disease of the liver after bone marrow transplantation: value of duplex sonography. American Journal of Roentgenology 1995; 164: 1397–1401
   PubMed Web of Science ®Google Scholar
• Jacobson A. F., Teefey S. A., Higano C. A., Bianco J. A. Increased lung uptake of 99Tcm-sulphur colloid as an early indicator of the development of hepatic veno-occlusive disease in bone marrow transplant patients. Nuclear Medicine Communications 1993; 14: 706–711
   PubMed Web of Science ®Google Scholar
• Hebard D. W., Jackson K. L., Christensen G. M. The chronological development of late radiation injury in the liver of the rat. Radiation Research 1980; 81: 441–454
   PubMed Web of Science ®Google Scholar
• Collins P. W., Gutteridge C. N., O'Driscoll A., Blair S., Jones L., Aitchison R., Kelsey S. M., Chopra R., Goldstone A., Newland A. C. von Willebrand factor as a marker of endothelial cell activation following BMT. Bone Marrow Transplantation 1992; 10: 499–506
   PubMed Web of Science ®Google Scholar
• Scrobohaci M. L., Drouet L., Monem-Manzi A., Devergie A., Baudin B., D'Agay M. F., Bluckman E. Liver veno-occlusive disease after bone marrow transplantation changes in coagulation parameters and endothelial markers. Thrombosis Research 1991; 63: 509–519
   PubMed Web of Science ®Google Scholar
• Bazarbachi A., Scrobohaci M. L., Gisselbrecht C., Marolleau J. P., Mansi A., Brice P., Gorra P., Drouet L. Changes in protein C, factor VII and endothelial markers after autologous bone marrow transplantation: possible implications in the pathogenesis of veno-occlusive disease. Nouvelle Revue Francais d Hématologie 1993; 35: 135–140
   PubMed Web of Science ®Google Scholar
• Gerlach H., Esposito C., Stern D. M. Modulation of endothelial hemostatic properties: an active role in the host response. Annual Review of Medicine 1990; 41: 15–24
   PubMed Web of Science ®Google Scholar
• Vannucchi A. M., Rafanelli D., Longo G., Bosi A., Guidi S., Saccardi R., Filimberti E., Cinotti S., Grossi A., Morfini M., Sossi-Ferrini P. Early hemostatic alterations following bone marrow transplantation: a prospective study. Haematologica 1994; 19: 519–525
   Google Scholar
• Collins P., Roderick A., O'Brien D., Tuddenham E., O'Driscoll A., Chopra R., Goldstone A., Newland A. Factor Vlla and other haemostatic variables following bone marrow transplantation. Thrombosis and Haemostasis 1994; 72: 28–32
   PubMed Web of Science ®Google Scholar
• Caron C., Jouet J. P., Facon T. Predictive value of haemostatic factors for hepatic VOD in allogeneic BMT. Bone Marrow Transplantation 1989; 4: 33
   PubMedGoogle Scholar
• Kaufman P. A., Jones R. B., Greenberg C. S., Peters W. P. Autologous bone marrow transplantation and factor XII, factor VII, and protein C deficiencies. Cancer 1991; 66: 515–521
   Web of Science ®Google Scholar
• Harper P. L., Jarvis J., Jennings I., Luddington R., Marcus R. E. Changes in the natural anticoagulants following bone marrow transplantation. Bone Marrow Transplantation 1990; 5: 39–42
   PubMed Web of Science ®Google Scholar
• Gordon B., Haire W., Kessinger A., Duggan M., Armitage J. High frequency of antithrombin 3 and protein C deficiency following autologous bone marrow trans-plantation for lymphoma. Bone Marrow Transplantation 1991; 8: 497–502
   PubMed Web of Science ®Google Scholar
• Faioni E. M., Krachmalnicoff A., Bearman S. I., Federici A. B., Decarli A., Gianni A. M., Macdonald G. B., Mannucci P. M. Naturally occurring anticoagulants and bone marrow transplantation: plasma protein C predicts the development of venocclusive disease of the liver. Blood 1993; 81: 3458–3462
   PubMed Web of Science ®Google Scholar
• Catani L., Gugliotta L., Mattioli Belmonte M., Vianelli N., Gherlinzoni F., Miggiano M. C., Belardinelli A. R., Rosti G., Calori E., Bandini G., Tura S. Hypercoagulability in patients undergoing autologous or alto-genic BMT for hematological malignancies. Bone Marrow Transplantation 1993; 12: 253–259
   PubMed Web of Science ®Google Scholar
• Salat C., Holler E., Reinhardt B., Kolb H. J., Seeber B., Ledderose G., Mittermueller J., Duell T., Wilmanns W., Hiller E. Parameters of the fibrinolytic system in patients undergoing BMT: elevation of PAI-1 in veno-occlusive disease. Bone Marrow Transplantation 1994; 14: 747–750
   PubMed Web of Science ®Google Scholar
• Rio B., Andreu G., Nicod A., Arrago J. P., Dutrillaux F., Samama M., Zittoun R. Thrombocytopenia in venocclusive disease after bone marrow transplantation or chemotherapy. Blood 1986; 67: 1773–1776
   PubMed Web of Science ®Google Scholar
• Mannucci P. M., Owen W. G. Basic and clinical aspects of proteins C and S. Haemostasis and Thrombosis, A. L. Bloom, D. P. Thomas. Churchill Livingstone, London 1987; 457
   Google Scholar
• Heikinheimo M., Halila R., Fasth A. Serum pro-collagen type III is an early and sensitive marker for venoocclusive disease of the liver in children undergoing bone marrow transplantation. Blood 1994; 83: 3036–3040
   PubMed Web of Science ®Google Scholar
• Rio B., Bauduer F., Arrago J. P., Zittoun R. N-terminal peptide of type III procollagen: a marker for the development of hepatic veno-occlusive disease after BMT and a basis for determining the timing of prophylactic heparin. Bone Marrow Transplantation 1993; 11: 471–472
   PubMed Web of Science ®Google Scholar
• Eltuni M., Trivedi P., Hobbs J. R., Portmann B., Cheeseman P., Downie C., Risteli J., Risteli L., Mowat A. P. Monitoring of veno-occlusive disease after bone marrow trans-plantation by serum aminopropeptide of type 111 procollagen. Lancet 1993; 342: 518–521
   PubMed Web of Science ®Google Scholar
• Gugliotta L., Catani L., Vianelli N., Gherlinzoni F., Miggiano M. C., Bandini G., Tura S. High plasma levels of tumor necrosis factor-α may be predictive of venoocclusive disease in bone marrow transplantation. Blood 1994; 83: 2385–2386
   PubMed Web of Science ®Google Scholar
• Cahn J. Y., Flesch M., Plouvier E., Herve P., Rozenbaum A. Maladie veino-occlusive du foie et autogreffe de moelle osseuse. Rôle préventif de l héparine. Nouvelle Revue Français d Hématologie 1985; 27: 27–28
   PubMedGoogle Scholar
• Rio B., Lamy T., Zittoun R. Preventive role of heparin for liver venocclusive disease (VOD). Bone Marrow Transplantation 1988; 3: 266, abstract
   Web of Science ®Google Scholar
• Bearman S. I., Hinds M. S., Wolford J. L., Petersen F. B., Nugent D. L., Slichter S. J., Shulman H. M., McDonald G. B. A pilot study of continuous infusion heparin for the prevention of hepatic veno-occlusive disease after bone marrow transplantation. Bone Marrow Transplantation 1990; 5: 407–411
   PubMed Web of Science ®Google Scholar
• Attal M., Huguet F., Rubie H., Huynh A., Charlet J.-P., Payen J.-L., Voigt J.-J., Brousset P., Selves J., Muller C., Pris J., Laurent G. Prevention of hepatic venoocclusive disease after bone marrow transplantation by continuous infusion of low-dose heparin: a prospective, randomised trial. Blood 1992; 79: 2834–2840
   PubMed Web of Science ®Google Scholar
• Baglin T. P., Harper P., Marcus R. E. Veno-occlusive disease of the liver complicating ABMT successfully treated with recombinant tissue plasminogen activator (rt-PA). Bone Marrow Transplantation 1990; 5: 439–441
   PubMed Web of Science ®Google Scholar
• Laporte Ph J., Lesage S., Tilleul P., Najman A., Gorin N. C. Alteplase for hepatic veno-occlusive disease complicating bone-marrow transplantation. Lancet 1992; 339: 1057
   PubMed Web of Science ®Google Scholar
• Rosti G., Bandini G., Belardinelli A., Calori E., Tura S., Gherlinzoni F., Miggiano C. Alteplase for hepatic veno-occlusive disease after bone-marrow transplantation. Lancet 1992; 339: 1481–1482
   PubMed Web of Science ®Google Scholar
• Simpson D. R., Browett P. J., Doak P. B., Palmer S. J. Successful treatment of veno-occlusive disease with recombinant tissue plasminogen activator in a patient requiring peritoneal dialysis. Bone Marrow Transplantation 1994; 14: 635–636
   PubMed Web of Science ®Google Scholar
• Espigado I., Rodriguez J. M., Parody R., Carmona M., Digon J., Olloqui E. Reversal of severe hepatic veno-occlusive disease by combined plasma exchange and rt-PA treatment. Bone Marrow Transplantation 1995; 16: 313–316
   PubMed Web of Science ®Google Scholar
• Bearman S. I., Shuhart M. C., Hinds M. S., McDonald G. B. Recombinant human tissue plasminogen activator for the treatment of established severe venocclusive disease of the liver after bone marrow transplantation. Blood 1992; 80: 2458–2462
   PubMed Web of Science ®Google Scholar
• Yu L. C., Malkani I., Regueira O., Ode D. L., Warrier R. P. Recombinant tissue plasminogen activator (rt-PA) for veno-occlusive liver disease in pediatric autologous bone marrow transplant patients. American Journal of Hematology 1994; 46: 194–198
   PubMed Web of Science ®Google Scholar
• Ibrahim A., Pico J. L., Maranchini D., Zambon E., Attal M., Brault P., Tilly H., Blaise D., Hayat M. Hepatic veno-occlusive disease following bone marrow transplantation treated by prostaglandin El. Bone Marrow Transplantation 1991; 7: 53, abstract
   PubMedGoogle Scholar
• Gluckman E., Jolivet I., Scrobohaci M. L., Devergie A., Traineau R., Bordeau-Esperou H., Lehn P., Faure P., Drouet L. Use of prostaglandin E1 for prevention of liver veno-occlusive disease in leukaemic patients treated by allogeneic bone marrow transplantation. British Journal of Haematology. 1990; 74: 277–281
   PubMed Web of Science ®Google Scholar
• Bianco J. A., Appelbaum F. R., Nemunaitis J., Almgren J., Andrews F., Kettner P., Shields A., Singer. Phase I-II trial of pentoxifylline for the prevention of transplant-related toxicities following bone marrow transplantation. Blood 1991; 78: 1205–1211
   PubMed Web of Science ®Google Scholar
• Esmon C. T., Taylor F. B., Jr., Snow T. R. Inflammation and coagulation: linked processes potentially regulated through a common pathway mediated by protein C. Thrombosis and Haemostasis 1991; 66: 160–165
   PubMed Web of Science ®Google Scholar
• Pichler L., Schramm W., Ulrich W., Varadi K., Schwarz H. P. Antinociceptive properties of protein C in a model of inflammatory hyperalgesia in rats. Thrombosis and Haemostasis 1995; 73: 252–255
   PubMed Web of Science ®Google Scholar